Tag: tivozanib

Home / tivozanib

Categories

Tivozanib has been approved by the FDA for the treatment of relapsed or refractory advanced renal cell carcinoma

August 2021: Tivozanib (Fotivda, AVEO Pharmaceuticals, Inc.), a kinase inhibitor, has been approved by the FDA for adult patients with relapsed or refractory advanced renal cell carcinoma (RCC) after ...
tivozanib

We Are Online! Chat With Us!
Scan the code